Cyclacel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $-35 | $0 | $10 |
Gross Profit | -39 | 10 | |
EBITDA | -5,036 | -2,176 | |
EBIT | -5,037 | -2,177 | |
Net Income | -81 | -3,052 | -1,957 |
Net Change In Cash | -35 | 0 | 10 |
Free Cash Flow | -3 | -1,356 | -3,067 |
Cash | 3,450 | 3,137 | 2,982 |
Basic Shares | 12 | 553 | 2,017 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43 | $420 | $373 | $0 |
Gross Profit | 43 | 420 | -32 | -43 |
EBITDA | -11,998 | -25,422 | -27,624 | -22,691 |
EBIT | -12,004 | -25,453 | -27,656 | -22,734 |
Net Income | -11,212 | -22,555 | -21,198 | -18,887 |
Net Change In Cash | 43 | 420 | 373 | 0 |
Free Cash Flow | -7,990 | -16,118 | -20,834 | -18,567 |
Cash | 3,137 | 3,378 | 18,345 | 36,559 |
Basic Shares | 8,305 | 797 | 750 | 595 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.34 |
2024-09-30 | -$0.18 |
2024-06-30 | -$0.72 |
2024-03-31 | -$2.27 |
